0
Thumbs Up |
Received: 1 Given: 1 |
Thumbs Up |
Received: 1 Given: 1 |
Thumbs Up |
Received: 6,852 Given: 3,187 |
It is long known that IQ is no longer a basis for measuring intellectual capacity.
Thumbs Up |
Received: 5,566 Given: 4,506 |
Thumbs Up |
Received: 1 Given: 1 |
Thumbs Up |
Received: 5,566 Given: 4,506 |
https://www.biogen.com/en_us/about-b...s_stelios.html
https://en.wikipedia.org/wiki/Aristides_PatrinosStelios Papadopoulos, Ph.D.
Chairman of the Board
Stelios Papadopoulos, Ph.D., has served on our Board of Directors since 2008 and was appointed as Chairman in June 2014. He is a member of our Audit Committee, Finance Committee and Science and Technology Committee. Dr. Papadopoulos is the Chairman of the Board of Directors of Exelixis, Inc., a drug discovery and development company that he co-founded in 1994. He is also the Chairman of Regulus Therapeutics, Inc., and a member of the Board of Directors of BG Medicine, Inc., both life sciences companies. He co-founded Anadys Pharmaceuticals, Inc., in 2000 and was a member of its Board of Directors until its acquisition by Hoffman-La Roche in 2011, serving as the Chairman of the board during 2011. In the not-for-profit sector, Dr. Papadopoulos is a co-founder and Chairman of Fondation Santé, a member of the Board of Visitors of Duke Medicine and a member of the Global Advisory Board of the Duke Institute for Health Innovation.
Dr. Papadopoulos retired as Vice Chairman of Cowen & Co., LLC, a financial services company, in 2006, after six years with the firm where, as an investment banker, he focused on the biotechnology and pharmaceutical sectors. Prior to joining Cowen, he spent 13 years as an investment banker at PaineWebber, Inc., where he was most recently Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. He joined PaineWebber in 1987 from Drexel Burnham Lambert where, as an analyst in the Equity Research Department, he covered the biotechnology industry. Prior to Drexel, he was the biotechnology analyst of Donaldson, Lufkin & Jenrette.
Before coming to Wall Street, Dr. Papadopoulos was on the faculty of the Department of Cell Biology at New York University School of Medicine. He maintains his affiliation with NYU as an adjunct associate professor of cell biology.
https://www.ellines.com/en/famous-gr...adership-team/Aristides Patrinos
From Wikipedia, the free encyclopedia
Dr. Aristides Patrinos (Greek: Αριστείδης Πατρινός), was born in 1947 to parents of Greek ancestry in Alexandria, Egypt. After attending and graduating Greek and British schools, in 1965 he left Cairo and moved to Athens, Greece. He studied engineering, both electrical and mechanical, at the National Technical University of Athens. Upon receiving his degree in 1970, he moved to the U.S. and studied in Chicago, Illinois at Northwestern University. In 1975, after receiving his Ph.D, he moved to New York State and taught at the University of Rochester. From there he worked with the Department of Energy and their national laboratories in New York state and Tennessee, eventually settling in Washington D.C., where he joined the Department of Energy full time.[1]
Aristides Patrinos Born Alexandria, Egypt Nationality Greek Egyptian American Fields genomics, mechanical, chemical, and biological engineering, structural biology, climate change, nuclear medicine Institutions NYU Alma mater National Technical University of Athens Known for Human Genome Project
In 1993 Dr. Patrinos succeeded David Galas as the Director of the “Office of Biological and Environmental Research” in the U.S. Department of Energy, where he then worked on the Human Genome Project. Leaving the Department of Energy in 2006, he joined Synthetic Genomics Inc. Having gained experience with a lead role in the Human Genome Project, Dr. Patrinos decided to launch the Genomes to Life Program as well as creating the DOE Joint Genome Institute. At DOE he was also involved in initiating the International Panel on Climate Change and the Global Change Research Program within the Department of energy. His work and research has defined many of the policies the United States employs with regard to these fields. [2]
Dr. Patrinos is considered a leading authority on structural biology, genomics, global environmental change, and nuclear medicine. He currently directs research for Urban Sciences and Progress or the CUSP program, and is also a professor of biological, chemical, and mechanical engineering at New York University. He continues to be involved with Synthetic Genome and their projects that involve synthetic biology applications, and also serves on the Board of Directors of Tsakos Energy and Navigation (TNP). To this day he continues his work in Washington D.C. advocating solutions for sustainable global energy and environmental change.[3]
He is married to Kathryn Hoff and they have two daughters, Thalia and Maritsa.
e.t.c.
Thumbs Up |
Received: 8 Given: 11 |
Thumbs Up |
Received: 7,248 Given: 4,031 |
Thumbs Up |
Received: 7,248 Given: 4,031 |
Thumbs Up |
Received: 14 Given: 3 |
There are currently 1 users browsing this thread. (0 members and 1 guests)
Bookmarks